Ken Griffin of Citadel sold 5.1 million shares of Palantir, reducing his stake by 91%. Meanwhile, he bought 4.7 million ...

Real-time index price for Nasdaq Biotechnology Index (NBI), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

Ken Griffin, the co-founder and CEO of Citadel LLC, has slashed his Palantir stock holdings by 91%, as revealed by a recent ...

Palantir's 30% YoY revenue increase raises questions on valuation. See why PLTR stock may need Nvidia-like growth to justify ...

Palantir CEO Alex Karp sat next to Tesla CEO Elon Musk at a closed-door U.S. Senate discussion on regulating AI last year.

Dubbed the Messi of AI growth, Palantir Technologies Inc. (NASDAQ:PLTR) has had a remarkable couple of years. The stock ...

The Palantir controversy escalated in 2019. Activists and human rights organizations criticized the company's contracts with ...

Musk could look to Palantir to modernize the Defense Department and reduce reliance on outdated methods of warfare, Cramer ...

Billionaire Israel Englander is the founder and CEO of Millennium Management, the second-most profitable hedge fund in ...

To be sure, some businesses with ties to Trump or his allies have seen their shares decline in value since the election. The ...

The Financial Times and the publisher of the Daily Mail are also betting on ProRata.ai, whose tech promises to credit and compensate artists and publishers for the use of their work by generative AI.

Ranmore’s founder Sean Peche dispenses with the narratives and takes a (very) close look at Palantir’s disclosed facts.